Ung2−/− 20-fold increase in lymphoid hyperplasia and B-cell lymphomas; deficiency increased hyper-IgM syndrome; Ung2−/− Msh2−/− accumulation of AID-dependent mutations in non-Ig target genes. This evidence concerns the gene AICDA and B-cell non-Hodgkin lymphoma.